Dinutuximab for the treatment of pediatric patients with neuroblastoma.
K. Greenwood, J. Foster
págs. 469-476
Dupilumab: human monoclonal antibody against IL-4Ralpha for moderate to severe atopic dermatitis.
David M. Paton
págs. 477-488
Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients.
Pablo Ureña Torres, Martine Cohen Solal, Jordi Bover Sanjuan
págs. 489-500
Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
Gaetano Romano
págs. 501-514
New product intros (daunorubicin/cytarabine, liposomal (new combination), deutetrabenazine (new indication), enasidenib mesylate, leuprorelin acetate (new indication), teneligliptin hydrobromide/canagliflozin (new combination).
págs. 515-516
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: